These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter? Grooteman MP; Nubé MJ Nephrol Dial Transplant; 2004 Dec; 19(12):2965-70. PubMed ID: 15507481 [No Abstract] [Full Text] [Related]
5. Biocompatibility and risk of infection in haemodialysis patients. Himmelfarb J; Hakim RM Nephrol Dial Transplant; 1994; 9 Suppl 2():138-44. PubMed ID: 8065605 [TBL] [Abstract][Full Text] [Related]
6. Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial. Kloppenburg WD; Stegeman CA; Hovinga TK; Vastenburg G; Vos P; de Jong PE; Huisman RM Nephrol Dial Transplant; 2004 May; 19(5):1212-23. PubMed ID: 14993506 [TBL] [Abstract][Full Text] [Related]
7. How much is enough? An investigation of the relationship between haemodialysis adequacy and quality of life of elderly patients. Zimbudzi E; Samlero R; Kerr PG; Zoungas S Nephrology (Carlton); 2016 Apr; 21(4):314-20. PubMed ID: 26369623 [TBL] [Abstract][Full Text] [Related]
8. [The influence of dialysis dose and the dialyzer membrane biocompatibility on the outcome of acute renal failure]. Kes P; Sefer S Lijec Vjesn; 1999; 121(9-10):326-8. PubMed ID: 19662688 [No Abstract] [Full Text] [Related]
9. Health-related quality of life among haemodialysis patients--relationship with clinical indicators, morbidity and mortality. Morsch CM; Gonçalves LF; Barros E J Clin Nurs; 2006 Apr; 15(4):498-504. PubMed ID: 16553764 [TBL] [Abstract][Full Text] [Related]
10. Adequacy in dialysis: intermittent versus continuous therapies. Misra M; Nolph KD Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the biocompatibility of haemodialysis membranes. Hakim RM Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426 [No Abstract] [Full Text] [Related]
12. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?]. Mandolfo S; Imbasciati E G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942 [TBL] [Abstract][Full Text] [Related]
13. Adequacy of hemodialysis and nutrition--important determinants of morbidity and mortality. Lindsay RM; Heidenheim AP; Spanner E; Kortas C; Blake PG Kidney Int Suppl; 1994 Jan; 44():S85-91. PubMed ID: 8127040 [No Abstract] [Full Text] [Related]
14. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis. Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Winkelmayer WC; van Biesen W; Crowe S; Kerr PG; Polkinghorne KR; Howard K; Pollock C; Hawley CM; Johnson DW; McDonald SP; Gallagher MP; Urquhart-Secord R; Craig JC; Trials; 2015 Aug; 16():364. PubMed ID: 26285819 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the biocompatibility of haemodialysis membranes. Schulman G; Hakim RM Nephrol Dial Transplant; 1991; 6 Suppl 2():10-3. PubMed ID: 1866056 [No Abstract] [Full Text] [Related]
17. Polymers in dialysis: characteristics and needs. Vienken J Med Device Technol; 2001; 12(1):18-22, 24, 27. PubMed ID: 11317861 [TBL] [Abstract][Full Text] [Related]
18. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility]. Szepietowski T; Krajewska M Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601 [TBL] [Abstract][Full Text] [Related]
19. Acute renal failure: role of dialysis membrane biocompatibility. Pascual M; Swinford RD; Tolkoff-Rubin N Annu Rev Med; 1997; 48():467-76. PubMed ID: 9046977 [TBL] [Abstract][Full Text] [Related]